<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03783858</url>
  </required_header>
  <id_info>
    <org_study_id>OPT1030</org_study_id>
    <nct_id>NCT03783858</nct_id>
  </id_info>
  <brief_title>Image Collection of Normal Eyes for Development of an EU RDB</brief_title>
  <official_title>Image Collection of Normal Eyes on the Optos P200TE for Development of an EU Reference Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Optos, PLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Optos, PLC</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to collect in-tissue OCT scans on the Optos P200TE on normal healthy
      eyes to develop a EU reference database
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 30, 2019</start_date>
  <completion_date type="Actual">April 20, 2020</completion_date>
  <primary_completion_date type="Actual">October 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Retinal thickness</measure>
    <time_frame>1 day</time_frame>
    <description>In general, descriptive statistics (n, mean, standard deviation, median, minimum and maximum) and 95% confidence interval for the mean will be used to summarize each scan parameters.
The 1st, 5th, 95th and 99th percentile results will be tabulated. All percentile results will be incorporated in the device software.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">356</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Single</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>P200TE</intervention_name>
    <description>OCT images</description>
    <arm_group_label>Single</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject 22 years of age or older on the date of informed consent

          2. Subject able to understand the written informed consent and willing to participate as
             evidenced by signing the informed consent

          3. Subject presenting at the site with normal eyes* (Cataracts and LASIK and PRK are
             allowed)

          4. BCVA 20/40 or better (each eye)

          5. Subject is able to comply with the study procedures in the view of the investigator
             *Normal eyes are defined as eyes judged normal for the subjects age as determined by
             the PI or sub-investigator

        Exclusion Criteria:

        1.1. Subject unable to tolerate ophthalmic imaging 2. Subject with ocular media not
        sufficiently clear to obtain acceptable OCT images 3. History of leukemia, dementia or
        multiple sclerosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tunde Peto, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queens University Belfast</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Simon Browning Optometrist</name>
      <address>
        <city>Bedford</city>
        <state>England</state>
        <zip>MK40 2SR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnard Levit Optometrists</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>NW11 7EL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>London Vision Clinic</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>W1G 7LA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queens University</name>
      <address>
        <city>Belfast</city>
        <state>Northern Ireland</state>
        <zip>BT7 1NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cameron Optometry</name>
      <address>
        <city>Edinburgh</city>
        <state>Scotland</state>
        <zip>EH3 6SW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 19, 2018</study_first_submitted>
  <study_first_submitted_qc>December 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2018</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

